MX2022014683A - Composiciones que comprenden acidos grasos y su uso. - Google Patents

Composiciones que comprenden acidos grasos y su uso.

Info

Publication number
MX2022014683A
MX2022014683A MX2022014683A MX2022014683A MX2022014683A MX 2022014683 A MX2022014683 A MX 2022014683A MX 2022014683 A MX2022014683 A MX 2022014683A MX 2022014683 A MX2022014683 A MX 2022014683A MX 2022014683 A MX2022014683 A MX 2022014683A
Authority
MX
Mexico
Prior art keywords
potential
compositions
fatty acids
composition
female subject
Prior art date
Application number
MX2022014683A
Other languages
English (en)
Inventor
Nora Schneider
Jonas Hauser
Sean Deoni
Tamas Bartfai
Zolezzi Irma Silva
Tinu Mary Samuel
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of MX2022014683A publication Critical patent/MX2022014683A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Ink Jet (AREA)

Abstract

La presente invención se refiere a una composición que comprende uno o más derivados de ácidos grasos para usar en la promoción, apoyo u optimización de uno o más de los siguientes: (i) mielinización de novo; (ii) estructura del cerebro: (iii) conectividad del cerebro; (iv) potencial intelectual; (v) potencial cognitivo; y (vi) potencial de aprendizaje; (vii) funcionamiento cognitivo en una cría de un sujeto femenino, en donde dicha composición es para la administración al sujeto femenino.
MX2022014683A 2016-03-30 2018-09-18 Composiciones que comprenden acidos grasos y su uso. MX2022014683A (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201662315152P 2016-03-30 2016-03-30
US201662315142P 2016-03-30 2016-03-30
US201662315134P 2016-03-30 2016-03-30
US201662315158P 2016-03-30 2016-03-30
US201662315163P 2016-03-30 2016-03-30
US201662328094P 2016-04-27 2016-04-27
PCT/EP2016/080786 WO2017167415A1 (en) 2016-03-30 2016-12-13 Compositions comprising fatty acids and their use

Publications (1)

Publication Number Publication Date
MX2022014683A true MX2022014683A (es) 2023-01-11

Family

ID=57614346

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2018008520A MX2018008520A (es) 2016-03-30 2016-12-13 Composiciones que comprenden acidos grasos y su uso.
MX2018011336A MX2018011336A (es) 2016-03-30 2017-03-30 Composiciones que comprenden acidos grasos y su uso.
MX2022014683A MX2022014683A (es) 2016-03-30 2018-09-18 Composiciones que comprenden acidos grasos y su uso.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
MX2018008520A MX2018008520A (es) 2016-03-30 2016-12-13 Composiciones que comprenden acidos grasos y su uso.
MX2018011336A MX2018011336A (es) 2016-03-30 2017-03-30 Composiciones que comprenden acidos grasos y su uso.

Country Status (8)

Country Link
EP (2) EP3984532A3 (es)
CN (2) CN108495627A (es)
BR (2) BR112018011412A2 (es)
CA (2) CA3003651A1 (es)
MX (3) MX2018008520A (es)
PH (2) PH12018501027A1 (es)
SG (2) SG11201803022TA (es)
WO (2) WO2017167415A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3643179A1 (en) * 2018-09-13 2020-04-29 Original Biological Technology Co., Ltd. Nutritional formula milk powder for congenital heart disease surgery and non-cardiac surgery and other intensive care infants, and use method thereof
CN109805390A (zh) * 2019-02-27 2019-05-28 云南大学 一种神经酸钙、神经酸锌及维生素k2复合物软胶囊
CN110946099A (zh) * 2019-12-13 2020-04-03 宁波大学 一种提高双壳贝类苗种繁育产量的方法
CN113508840A (zh) * 2020-04-09 2021-10-19 北京三元食品股份有限公司 乳脂球膜在制备孕妇奶粉中的应用
CN114544821B (zh) * 2020-11-24 2023-10-24 重庆医科大学 检测血浆中磷脂酰乙醇胺（36:4）的试剂在制备抑郁症检测试剂盒中的用途
WO2024038010A1 (en) 2022-08-18 2024-02-22 Société des Produits Nestlé S.A. Kit to promote developmental myelination
CN116008438B (zh) * 2023-02-07 2023-06-06 北京三元食品股份有限公司 一种用于评价婴幼儿精细动作发育状况的标志物组及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322589B1 (fr) 1987-12-23 1993-01-20 Societe Des Produits Nestle S.A. Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques
GB9416846D0 (en) * 1994-08-19 1994-10-12 Croda Int Plc Lipid supplementation
EP0880902A1 (fr) 1997-05-27 1998-12-02 Nestlé Produkte AG Procédé de traitement d'une matiére première lactosérique
AU4555799A (en) * 1998-06-12 1999-12-30 Craig Anthony Cooney Nutritional methyl supplements change epigenetics, dna methylation, phenotype, and appearance of mammalian offspring
CN100413423C (zh) 1999-04-29 2008-08-27 雀巢制品公司 用于具有低苏氨酸含量的婴儿配制食品的组合物
WO2003017945A2 (en) * 2001-08-24 2003-03-06 Martek Biosciences Boulder Corporation Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum
MX2007011046A (es) * 2005-03-10 2007-11-14 Sciele Pharma Inc Preparaciones nutritivas.
EP1898722B1 (en) * 2005-04-28 2013-04-10 Enzymotec Ltd. Polar lipid mixtures, their preparation and uses
AU2006251569B2 (en) * 2005-05-23 2012-06-21 Massachusetts Institute Of Technology Compostions containing pufa and/or uridine and methods of use thereof
KR101430214B1 (ko) * 2006-12-28 2014-08-18 산토리 홀딩스 가부시키가이샤 신경 재생제
EP2110027A1 (en) * 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula

Also Published As

Publication number Publication date
EP3984532A2 (en) 2022-04-20
CN108778265A (zh) 2018-11-09
WO2017167415A1 (en) 2017-10-05
BR112018011412A2 (pt) 2018-12-04
PH12018550141A1 (en) 2019-03-11
CA3015028A1 (en) 2017-10-05
WO2017167899A1 (en) 2017-10-05
SG11201803022TA (en) 2018-05-30
EP3435997A1 (en) 2019-02-06
MX2018008520A (es) 2018-08-16
EP3984532A3 (en) 2022-09-21
PH12018501027A1 (en) 2019-01-28
CA3003651A1 (en) 2017-10-05
BR112018067999A2 (pt) 2019-01-15
CN108495627A (zh) 2018-09-04
SG11201806545WA (en) 2018-10-30
MX2018011336A (es) 2019-01-31

Similar Documents

Publication Publication Date Title
MX2022014683A (es) Composiciones que comprenden acidos grasos y su uso.
PH12018500752A1 (en) Nutritional composition and infant formula for promoting myelination of the brain
MX2022012236A (es) Composiciones que comprenden colina y su uso.
PH12017502331A1 (en) 1,4-substituted piperidine derivatives
PH12016500216B1 (en) Stable pharmaceutical composition and methods of using same
MA39985B1 (fr) 1h-pyrrolo [2,3-c]pyridine -7(6h)-ones et pyrazolo[3,4-c]pyridine-7(6h)-ones en tant qu'inhibiteurs de protéines bet
WO2013075116A3 (en) Omega 7 rich compositions and methods of isolating omega 7 fatty acids
MX2022012237A (es) Composiciones que comprenden fosfolipido y su uso.
MX2017016370A (es) Derivados de 4-bencil y 4-benzoil piperidina sustituidos.
PH12017500059B1 (en) Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof
PH12018501129A1 (en) Compositions comprising vitamins and their use
MX2019006920A (es) Derivados de la espiropiperidina.
MX2022014682A (es) Composiciones y su uso.
WO2017167898A3 (en) Compositions comprising vitamins and their use
BR112018069629A2 (pt) processo para fazer uma composição de nanoemulsão
MX2018006293A (es) Composicion nutritiva y formula infantil para promover la mielinizacion del cerebro.
PH12018501029A1 (en) Compositions comprising choline and their use
MX2019007315A (es) Metodos para producir biomasa rica en dha, acido palmitico y proteinas con un microorganismo eucariota.
MX2018001414A (es) Sal del ester metilico dihidrofenilglicina.
MX2015005235A (es) Metodo para reducir trigliceridos.